Related references
Note: Only part of the references are listed.Effectiveness and Safety of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes Previously Treated with Continuous Subcutaneous Insulin Infusion and Flash Glucose Monitoring
Noelia Gros Herguido et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2023)
MiniMed 780G™ in 2-to 6-Year-Old Children: Safety and Clinical Outcomes After the First 12 Weeks
Mari-Anne Pulkkinen et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2023)
Outcomes of hybrid closed-loop insulin delivery activated 24/7 versus evening and night in free-living prepubertal children with type 1 diabetes: A multicentre, randomized clinical trial
Eric Renard et al.
DIABETES OBESITY & METABOLISM (2022)
Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece
Vaia Lambadiari et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2022)
Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial
Gregory P. Forlenza et al.
PEDIATRIC DIABETES (2022)
A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes
Marta Bassi et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users
Julien Da Silva et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2022)
Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real-world users
Arcelia Arrieta et al.
DIABETES OBESITY & METABOLISM (2022)
Real-world prospective observational single-centre study: Hybrid closed loop improves HbA1c, time-in-range and quality of life for children, young people and their carers
Sze May Ng et al.
DIABETIC MEDICINE (2022)
Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus
Basilio Pintaudi et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)
Intermittent Scanning Glucose Monitoring or Predicted Low Suspend Pump Treatment: Does It Impact Time in Glucose Target and Treatment Preference? The QUEST Randomized Crossover Study
Ulrike Schierloh et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Predictors of time in target glucose range in real-world users of the MiniMed 780G system
Javier Castaneda et al.
DIABETES OBESITY & METABOLISM (2022)
Insulin Requirements for Basal and Auto-Correction Insulin Delivery in Advanced Hybrid Closed-Loop System: 4193 Days’ Real-World Data of Children in Two Different Age Groups
Kağan Ege Karakuş et al.
Journal of diabetes science and technology (2022)
Long-term outcomes of an advanced hybrid closed-loop system: A focus on different subpopulations
Pilar Isabel Beato-Vibora et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2022)
Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable-1-year prospective, observational, two-center study
Sebastian Seget et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Pumps that predict and manage low blood glucose are superior to pumps with stand-alone CGM for reducing hypoglycaemia in type 1 diabetes patients in a real-world setting
C. Telliam et al.
DIABETES & METABOLISM (2021)
Real-world outcomes with different technology modalities in type 1 diabetes
Pilar Beato-Vibora et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)
Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes
Pilar Isabel Beato-Vibora et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Six-Month Effectiveness of Advanced vs. Standard Hybrid Closed-Loop System in Children and Adolescents With Type 1 Diabetes Mellitus
Gianluca Tornese et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
MiniMedTM780G Insulin pump system with smartphone connectivity for the treatment of type 1 diabetes: overview of its safety and efficacy
Jennifer McVean et al.
EXPERT REVIEW OF MEDICAL DEVICES (2021)
Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents
Erin C. Cobry et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion
Guy G. Massa et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes
Marine Halbron et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
The road from intermittently scanned continuous glucose monitoring to hybrid closed-loop systems. Part B: results from randomized controlled trials
Francesca De Ridder et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2019)
The road from intermittently scanned glucose monitoring to hybrid closed-loop systems: Part A. Keys to success: subject profiles, choice of systems, education
Francesca De Ridder et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2019)
Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study
Monika Reddy et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion
Jesus Moreno-Fernandez et al.
ENDOCRINOLOGIA DIABETES Y NUTRICION (2018)
The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes
Veronique Gingras et al.
DIABETES OBESITY & METABOLISM (2018)
The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis
Tatyana Mollayeva et al.
SLEEP MEDICINE REVIEWS (2016)